FDA Official Gives Policy Update On Lab-Developed Tests
Most laboratory-developed tests have no predicates, said Elizabeth Mansfield, director of personalized medicine in CDRH’s diagnostics office, hinting that many may require pre-market submissions that go beyond 510(k) review standards once the agency initiates plans for active oversight of the category.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
